Makale Başlığı: The effects of N-acetylcysteine (NAC) used in critical COVID-19 patients on clinical findings, inflammatory parameters and kidney functions
Özet: Objective: In this study, N-acetylcysteine (NAC) was used in critically ill patients who needed tertiary care due to COVID-19; The effects on clinical findings, inflammatory parameters and kidney functions were investigated.Materials and Methods: 190 adult patients with confirmed COVID-19 PCR positivity between April and September 2020 were included in this single-center retrospective study. The clinical and laboratory findings of the patients who received NAC (2400mg/day intravenously once a day) in addition to the standard treatment and the patients who were given the standard treatment alone were compared.Results: Age (p=0.423), gender (p=0.086), intubation (p=0.196), death (p=0.387), hospitalization (p=0.085), and intensive care unit stay (p=0.584) between groups There was no difference in terms of No significant difference was found between those who took NAC and those who did not, in the values of CRP (C-reactive protein), ferritin, fibrinogen, neutrophil, lymphocyte count, D-dimer, and creatinine measured on the first day, third day, seventh day, tenth day and fifteenth day (p> 0.05).Conclusion: NAC treatment did not affect the number of deaths, hospitalization and intensive care hospitalization days in patients admitted to the 3rd line intensive care unit due to COVID-19. At the same time, it did not show a positive or negative effect on inflammatory parameters and kidney functions.
Yazar isimleri: ['Mine ALTINKAYA ÇAVUŞ', 'Hilal SİPAHİOĞLU']
Yayın Yılı: 25 Ekim 2022
Dergi ismi: Aksaray Üniversitesi Tıp Bilimleri Dergisi
Yayın sayfa url: https://dergipark.org.tr/tr/pub/asujms/issue/73171/1062868
Yayın pdf linki: https://dergipark.org.tr/tr/download/article-file/2212262
